TipRanks
Virax Biolabs Group Ltd. Class A (VRAX)
NASDAQ:VRAX
US Market
VRAX
Virax Biolabs Group Ltd. Class A
RESEARCH TOOLSreports

Virax Biolabs Group Ltd. Class A (VRAX) Ratios

171 Followers

Virax Biolabs Group Ltd. Class A Ratios

VRAX's free cash flow for Q4 2026 was $0.62. For the 2026 fiscal year, VRAX's free cash flow was decreased by $ and operating cash flow was $-472.56. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 9.97 9.97 7.27 25.94 10.61
Quick Ratio
 9.90 9.90 7.13 25.58 10.58
Cash Ratio
 9.40 9.40 6.28 21.26 10.30
Solvency Ratio
 -6.85 -4.63 -5.93 -19.21 -6.01
Operating Cash Flow Ratio
 -11.01 -6.75 -6.78 -37.00 -4.60
Short-Term Operating Cash Flow Coverage
 -264.96 -162.30 -140.56 0.00 -28.58
Net Current Asset Value
$ 5.84M$ 5.84M$ 3.93M$ 4.04M$ 8.73M
Leverage Ratios
Debt-to-Assets Ratio
 0.05 0.05 0.06 0.04 0.01
Debt-to-Equity Ratio
 0.05 0.05 0.07 0.04 0.02
Debt-to-Capital Ratio
 0.05 0.05 0.06 0.04 0.02
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.10 1.10 1.13 1.02 1.08
Debt Service Coverage Ratio
 -55.30 -50.21 -62.50 -245.89 -33.65
Interest Coverage Ratio
 -96.86 -103.60 -105.93 -241.70 -370.62
Debt to Market Cap
 0.06 0.01 <0.01 0.00 0.02
Interest Debt Per Share
 1.28 1.20 3.51 0.13 0.15
Net Debt to EBITDA
 0.76 1.11 0.66 0.51 1.69
Profitability Margins
Gross Profit Margin
-1480.46%61.90%-838.21%32.34%-15.94%
EBIT Margin
-60270.31%-47256.31%-97073.35%-4291.19%-63570.74%
EBITDA Margin
-56151.36%-43722.40%-91649.46%-4225.28%-63570.74%
Operating Profit Margin
-64038.24%-51515.17%-97344.76%-4153.25%-66963.67%
Pretax Profit Margin
-60931.44%-47753.55%-97992.31%-4308.38%-63751.47%
Net Profit Margin
-52473.24%-40439.10%-95739.17%-4304.81%-63748.32%
Continuous Operations Profit Margin
-52565.44%-40507.00%-95833.71%-4308.38%-63751.47%
Net Income Per EBT
86.12%84.68%97.70%99.92%100.00%
EBT Per EBIT
95.15%92.70%100.67%103.74%95.20%
Return on Assets (ROA)
-88.44%-60.35%-94.31%-122.79%-55.62%
Return on Equity (ROE)
-114.24%-66.30%-106.41%-125.47%-59.80%
Return on Capital Employed (ROCE)
-117.61%-83.77%-107.11%-122.23%-64.38%
Return on Invested Capital (ROIC)
-100.03%-70.05%-103.22%-121.13%-63.34%
Return on Tangible Assets
-88.44%-60.35%-94.90%-123.91%-56.65%
Earnings Yield
-729.05%-229.74%-171.67%-456.60%-73.83%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.21 0.72 0.00
Payables Turnover
 4.28 0.09 1.06 2.32 0.06
Inventory Turnover
 4.62 0.10 0.63 1.75 0.41
Fixed Asset Turnover
 <0.01 <0.01 <0.01 0.14 0.00
Asset Turnover
 <0.01 <0.01 <0.01 0.03 <0.01
Working Capital Turnover Ratio
 <0.01 <0.01 <0.01 0.02 <0.01
Cash Conversion Cycle
 -6.13 -287.19 2.00K 559.21 -4.99K
Days of Sales Outstanding
 0.00 0.00 1.77K 508.33 0.00
Days of Inventory Outstanding
 79.08 3.70K 581.78 208.26 886.02
Days of Payables Outstanding
 85.20 3.99K 344.69 157.38 5.88K
Operating Cycle
 79.08 3.70K 2.35K 716.59 886.02
Cash Flow Ratios
Operating Cash Flow Per Share
 -18.98 -11.62 -36.84 -3.11 -3.93
Free Cash Flow Per Share
 -19.98 -12.27 -41.71 -3.69 -4.10
CapEx Per Share
 1.00 0.64 4.87 0.58 0.17
Free Cash Flow to Operating Cash Flow
 1.05 1.06 1.13 1.19 1.04
Dividend Paid and CapEx Coverage Ratio
 -18.99 -18.07 -7.56 -5.36 -23.43
Capital Expenditure Coverage Ratio
 -18.99 -18.07 -7.56 -5.36 -23.43
Operating Cash Flow Coverage Ratio
 -18.21 -11.15 -12.10 -27.85 -28.58
Operating Cash Flow to Sales Ratio
 -537.76 -372.04 -720.83 -39.94 -488.23
Free Cash Flow Yield
-1675.56%-223.06%-146.36%-502.57%-58.96%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.10 -0.44 -0.58 -0.22 -1.35
Price-to-Sales (P/S) Ratio
 33.78 176.02 557.68 9.43 863.45
Price-to-Book (P/B) Ratio
 0.13 0.29 0.62 0.27 0.81
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.06 -0.45 -0.68 -0.20 -1.70
Price-to-Operating Cash Flow Ratio
 -0.13 -0.47 -0.77 -0.24 -1.77
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 <0.01 0.01 <0.01 >-0.01
Price-to-Fair Value
 0.13 0.29 0.62 0.27 0.81
Enterprise Value Multiple
 0.70 0.71 0.06 0.29 0.33
Enterprise Value
 -5.55M -3.84M -321.25K -1.89M -1.81M
EV to EBITDA
 0.70 0.71 0.06 0.29 0.33
EV to Sales
 -395.59 -308.93 -50.74 -12.08 -211.93
EV to Free Cash Flow
 0.70 0.79 0.06 0.26 0.42
EV to Operating Cash Flow
 0.74 0.83 0.07 0.30 0.43
Tangible Book Value Per Share
 18.45 18.45 43.77 2.54 8.21
Shareholders’ Equity Per Share
 19.06 19.06 45.98 2.67 8.59
Tax and Other Ratios
Effective Tax Rate
 0.14 0.15 0.02 0.00 0.00
Revenue Per Share
 0.04 0.03 0.05 0.08 <0.01
Net Income Per Share
 -18.52 -12.64 -48.93 -3.36 -5.13
Tax Burden
 0.86 0.85 0.98 1.00 1.00
Interest Burden
 1.01 1.01 1.01 1.00 1.00
Research & Development to Revenue
 364.77 300.92 281.12 9.99 46.39
SG&A to Revenue
 260.81 214.85 683.94 29.37 619.98
Stock-Based Compensation to Revenue
 9.29 10.50 57.70 6.47 202.62
Income Quality
 1.02 0.92 0.75 0.93 0.77
Currency in USD